You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glycopyrrolate

Showing 1 - 25 of 321
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PIK3CA E545A Trial (Glycopyrrolate, Anisodamine)

Not yet recruiting
  • PIK3CA E545A
  • (no location specified)
Sep 17, 2023

Bradyarrhythmia, Cardiac Arrest, Tachycardia Trial in Kathmandu (Normal Saline, Glycopyrrolate)

Completed
  • Bradyarrhythmia
  • +3 more
  • Normal Saline
  • Glycopyrrolate
  • Kathmandu, Nepal
    National Academy of Medical Sciences
Aug 9, 2023

Spine Surgery, Reversal of Neuromuscular Blockade, Urinary Retention Postoperative Trial (Sugammadex, Neostigmine,

Not yet recruiting
  • Spine Surgery
  • +2 more
  • (no location specified)
May 24, 2023

Glycopyrrolate, Colonoscopy Trial in Chongqing (Glycopyrrolate, Placebo)

Not yet recruiting
  • Glycopyrrolate
  • Colonoscopy
  • Glycopyrrolate
  • Placebo
  • Chongqing, Chongqing, China
    The Second Affiliated Hospital Of Chongqing Medical University
Sep 12, 2023

Glycopyrrolate Trial in Yangzhou (Glycopyrrolate, normal saline)

Recruiting
  • Glycopyrrolate
  • Glycopyrrolate
  • normal saline
  • Yangzhou, Jiangsu, China
    the Affiliated Hospital of Yangzhou University, Yangzhou Univers
Jan 12, 2023

Neuromuscular Blockade Trial in Montreal (Neostigmine and glycopyrrolate, Sugammadex)

Recruiting
  • Neuromuscular Blockade
  • Montreal, Quebec, Canada
    CIUSSS de l'Est de l'Ile de Montreal
Jan 30, 2023

Intestinal Disease Trial in Orange (Neostigmine Injectable Solution, Sugammadex injection)

Not yet recruiting
  • Intestinal Disease
  • Neostigmine Injectable Solution
  • Sugammadex injection
  • Orange, California
    UC Irvine Medical Center
Oct 31, 2023

Hernia, Ventral, Ileus Trial in Cleveland (Neostigmine / Glycopyrrolate, Sugammadex)

Not yet recruiting
  • Hernia, Ventral
  • Ileus
  • Cleveland, Ohio
    Cleveland Clinic Center for Abdominal Core Health
Aug 8, 2023

Pulmonary Disease, Chronic Obstructive Trial in Manchester (Glycopyrrolate, Comparator)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Manchester, United Kingdom
    Medicines Evaluation Unit Ltd.
Oct 28, 2021

Neuromuscular Blockade, COPD Trial in Philadelphia (neostigmine/glycopyrrolate, sugammadex)

Recruiting
  • Neuromuscular Blockade
  • Chronic Obstructive Pulmonary Disease
  • Philadelphia, Pennsylvania
    Temple University Hospital
Apr 26, 2022

COPD Trial in Antwerpen (Glycopyrrolate + Formoterol, Glycopyrrolate, Formoterol)

Completed
  • COPD
  • Glycopyrrolate + Formoterol
  • +3 more
  • Antwerpen, Lange Beeldekensstraat 267, Belgium
    Clinical Pharmacology Unit - SGS Life Science Services
Oct 28, 2021

Bladder Irritable Trial (Glycopyrrolate + dexmedetomidine, Dexmedetomidine)

Withdrawn
  • Bladder Irritable
  • (no location specified)
Aug 17, 2021

Spinal Cord Injuries, Constipation, Fecal Incontinence Trial in Bronx (Combination of Neostigmine and Glycopyrrolate, I-Box by

Recruiting
  • Spinal Cord Injuries
  • +3 more
  • Combination of Neostigmine and Glycopyrrolate
  • I-Box by Dynatronics
  • Bronx, New York
    James J Peters VA Medical Center
Sep 22, 2021

Healthy Trial in Manchester (Glycopyrrolate)

Completed
  • Healthy
  • Glycopyrrolate
  • Manchester, United Kingdom
    Medicines Evaluation Unit
Oct 28, 2021

Postoperative Urinary Retention Trial in Morgantown (Sugammadex)

Not yet recruiting
  • Postoperative Urinary Retention
  • Morgantown, West Virginia
    West Virginia University Hospitals
Dec 22, 2022

Surgery Trial in United States (Neostigmine+glycopyrrolate, Sugammadex)

Completed
  • Surgery
  • Basking Ridge, New Jersey
  • +3 more
Mar 4, 2022

COPD Trial in Szeged (Beclometasone/Formoterol/Glycopyrrolate, Beclometasone/Formoterol)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Szeged, Hungary
    Dr Beatrix BALINT
Oct 28, 2021

Hip and Knee Surgery Trial in Cleveland (Neostigmine, Sugammadex)

Not yet recruiting
  • Neuromuscular Blockade
  • Cleveland, Ohio
    Cleveland Clinic
Feb 1, 2023

COPD (COPD) Trial in Manchester (Glycopyrrolate, Tiotropium, )

Completed
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Glycopyrrolate
  • +2 more
  • Manchester, United Kingdom
    Medicines Evaluation Unit
Oct 28, 2021

Hyperhidrosis Trial in United States (glycopyrrolate, 1.0%, glycopyrrolate, 2.0%, glycopyrrolate, 3.0%)

Completed
Has Results
  • Hyperhidrosis
  • glycopyrrolate, 1.0%
  • +4 more
  • Hot Springs, Arkansas
  • +20 more
Aug 23, 2021

Neuromuscular Blockade, Anesthesia Trial in Cleveland (Neostigmine, Glycopyrrolate, Sugammadex)

Completed
Has Results
  • Neuromuscular Blockade
  • Anesthesia
  • Cleveland, Ohio
    Cleveland Clinic
Oct 19, 2021

COPD Trial in Hessen, Szeged, Perugia (BDP/FF/GB, Tiotropium, BDP/FF + Tiotropium)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Hessen, Germany
  • +2 more
Oct 28, 2021

Hyperhidrosis Trial in Canada, United States (Dose 1 of glycopyrrolate, 2.0% QD, Dose 2 of glycopyrrolate, 3.0% QD, Dose 1 of

Completed
Has Results
  • Hyperhidrosis
  • Dose 1 of glycopyrrolate, 2.0% QD
  • +4 more
  • Encinitas, California
  • +14 more
Aug 23, 2021

Burns Trial in Kansas City (Sugammadex, Neostigmine, Glycopyrrolate)

Recruiting
  • Burns
  • Kansas City, Kansas
    University of Kansas Medical Center
May 2, 2022

COPD Trial in United States (Budesonide/glycopyrrolate/formoterol fumarate (Breztri Aerosphere) 320 µg/18 µg/9.6 µg administered

Not yet recruiting
  • COPD
  • Budesonide/glycopyrrolate/formoterol fumarate (Breztri Aerosphere) 320 μg/18 μg/9.6 μg administered as two inhalations, twice daily.
  • External Comparator
  • Tampa, Florida
  • +6 more
Jul 21, 2023